Association of baseline higher platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios with less durable radiographic response to immune checkpoint inhibitors in non-small cell lung cancer.

e21137Background: Immune checkpoint inhibitors (ICI) are the standard of care in the treatment of non-small cell lung cancer (NSCLC). ICIs are commonly used in combination with chemotherapy but may...